6 JANUARYNeurotechnology devices are gaining ground with massive advancements in signal quality, biofeedback, and hardware to obtain better insights into the nervous system and activities of the brain. Startups and established neurotech companies are fueling innovation to develop neurotechnology devices that deliver better outcomes and personalised therapies.These cutting-edge developments are driving the growth of the neurotech market, which is estimated to reach $21.9 billion by 2026 at a CAGR of 15.3 percent during the forecast period. Recent market analysis reports identify the market growth is due to the rising incidence of neurological diseases such as brain tumors, epilepsy, Alzheimer's, multiple sclerosis, and Parkinson's in patients and the indispensable need to diagnose, prevent, and treat them. Neurostimulation among the various segments of neurotech is a predominant factor boosting the market growth from the adoption of deep brain stimulation to treat patients suffering from epilepsy, dystonia, tremors and Parkinson's disease.To bring the spotlight on the vital developments in the neurotech industry, Healthcare Business Review illustrates how neurotechnology companies are enhancing their operations and meeting business goals by leveraging cutting-edge neuroscience technologies. The edition features thought leadership articles from Michael King, Chief Medical Officer at Upperline Health, who sheds light on non-invasive methods for managing peripheral neuropathy. It also includes insights from David Baker, Chief Information and Digital Officer at Pacific Dental Services, who talks about transforming systemic health by implementing EHR in dentistry.The edition also presents some of the top neurotech companies that deliver the best outcomes for their clients, notably BrainTap Technologies, an advanced wellness and fitness company boosting brain fitness and transforming the lives of many through its advanced neuro algorithm.We hope you find the right neurotechnology company to assist you with the industry-best diagnosis and treatment options to significantly improve and rehabilitate patients' brain health.Let us know your thoughts!Alex D'souzaManaging Editoreditor@healthcarebusinessreview.comDriving Next-Generation Neurology Therapeutics EditorialManaging EditorAlex D'souzaEditorial StaffAaron PaulGina ClumskyJoe PhillipJames SmithMark RobertYenny TurnerVisualizerCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.JANUARY, volume 05 - Issue 13 Published by ValleyMedia, Inc. To subscribe to Healthcare Business ReviewVisit www.healthcarebusinessreview.com Email:sales@healthcarebusinessreview.comeditor@healthcarebusinessreview.commarketing@healthcarebusinessreview.comChirs LynnMichael WayneDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOs
< Page 5 | Page 7 >
< Page 5 | Page 7 >